Patent offices

Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations

Retrieved on: 
Thursday, July 29, 2021

The allowed claims cover composition of matter for the company's proprietary formulations for use in treating wounds and skin infections and in personal care formulations.

Key Points: 
  • The allowed claims cover composition of matter for the company's proprietary formulations for use in treating wounds and skin infections and in personal care formulations.
  • A Decision to Grant is the European Examiners confirmation that the European Patent Office has decided to grant Kane the patent and has set the grant date.
  • "These patents are important additions to the existing portfolio covering Kanes coactiv+ technology platform," saidGordon Guay, the company's Chief Scientific Officer.
  • Its multi-functional and gentle formulation makes it a perfect companion treatment to DispersinB Hydrogel, also part of the Kane Biotech antibiofilm wound care portfolio.

United Inventors Association Announces Inspire 2021

Retrieved on: 
Wednesday, July 21, 2021

WASHINGTON, July 21, 2021 /PRNewswire/ -- The United Inventors Association of America (UIA), a national 501c3 non-profit dedicated to educating inventors, patent holders and product developers, has announced "Inspire 2021," a three-day virtual conference, Wednesday, September 15, Friday, September 17 and Saturday, September 18, 2021.

Key Points: 
  • WASHINGTON, July 21, 2021 /PRNewswire/ -- The United Inventors Association of America (UIA), a national 501c3 non-profit dedicated to educating inventors, patent holders and product developers, has announced "Inspire 2021," a three-day virtual conference, Wednesday, September 15, Friday, September 17 and Saturday, September 18, 2021.
  • "Holding 'Inspire 2021' allows us to educate inventors nationally and internationally while providing opportunities to pitch experts to secure product distribution.
  • About the UIA: The UIA began as an outreach program to inventors for the United States Patent Office (USPTO).The mission of the UIA is empowering inventors through education, access and advocacy.
  • For more information on local inventor's clubs and securing free membership in the United Inventors Association, visit www.UIAUSA.org .

GBT - 3D CHIP and MEMORY Patent Will Be Published in Europe

Retrieved on: 
Wednesday, July 21, 2021

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- GBT   Technologies   Inc.   ( OTC PINK: GTCH ) ("GBT” or the “Company”), is pleased to report the upcoming publication of its 3D CHIP and MEMORY patent in Europe on July 28, 2021. The application has been allocated the number 19862631.9 and designates all European Patent Convention (“EPC”) states, as of the Patent Cooperation Treaty (“PCT”) filing date.

Key Points: 
  • SANDIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK: GTCH ) ("GBT or the Company), is pleased to report the upcoming publication of its3D CHIP and MEMORY patent in Europe on July 28, 2021.
  • The application has been allocated the number 19862631.9 and designates all European Patent Convention (EPC) states, as of the Patent Cooperation Treaty (PCT) filing date.
  • The companys 3D microchip patent was filed on March 5, 2019 and was granted as of December 1, 2020 by the United States Patent and Trademark Office (USPTO); U.S. Patent No.
  • The bibliographic data of the above-mentioned Euro-PCT application will be published on28.07.21 in Section 1.1 of the European Patent Bulletin.

USPTO Awards SproutLoud Patent for Change Management System in Co-Op Marketing

Retrieved on: 
Thursday, July 15, 2021

Marketing technology company SproutLoud is proud to announce that it has been awarded a second patent from the United States Patent and Trademark Office (USPTO), protecting its innovative distributed marketing ecosystems.

Key Points: 
  • Marketing technology company SproutLoud is proud to announce that it has been awarded a second patent from the United States Patent and Trademark Office (USPTO), protecting its innovative distributed marketing ecosystems.
  • This new patent specifically covers SproutLouds Co-Op Marketing model, which supports change management by helping clients move from reimbursement systems to co-pay.
  • SproutLoud has been thoughtful about how it institutes change for Co-Op Marketing systems.
  • SproutLoud built its change management process and associated features into its proprietary marketing technology stack, which is a significant differentiation within the Through Channel Marketing Automation industry.

TrippBio receives Notice of Allowance from the U.S. Patent Office for Therapeutic Treatment of COVID-19 Infections

Retrieved on: 
Thursday, July 15, 2021

JACKSONVILLE, Fla., July 15, 2021 /PRNewswire-PRWeb/ --TrippBio, Inc. (TrippBio), a clinical development-stage company developing antiviral treatments with an initial focus on COVID-19, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.

Key Points: 
  • JACKSONVILLE, Fla., July 15, 2021 /PRNewswire-PRWeb/ --TrippBio, Inc. (TrippBio), a clinical development-stage company developing antiviral treatments with an initial focus on COVID-19, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.
  • 16/875,487, and the European Patent Office (EPO) has issued a favorable opinion in a counterpart European application.
  • The availability of safe and effective treatment options can reduce the rate of hospitalizations and hopefully the long-term effects of COVID-19."
  • TrippBio is founded on the scientific research of Ralph Tripp, Ph.D., Georgia Research Alliance Chair and professor at the University of Georgia.

US Patent and Trademark Office Grants Patent to Ventegra for Its Acquisition Cost Index (ACI) Cost-Plus Pricing Reimbursement Technology Platform for Prescription Drugs

Retrieved on: 
Tuesday, July 13, 2021

The US Patent and Trademark Office (USPTO) has granted US patent number 11,023,979 B2 (June 1, 2021) that covers Ventegras Acquisition Cost Index (ACI) cost-based reimbursement technology (Reference Price Index) through 2034.

Key Points: 
  • The US Patent and Trademark Office (USPTO) has granted US patent number 11,023,979 B2 (June 1, 2021) that covers Ventegras Acquisition Cost Index (ACI) cost-based reimbursement technology (Reference Price Index) through 2034.
  • The technology makes it possible to replace antiquated reimbursement practices, certifying that clients are billed the same amount as the pharmacy was paid.
  • By updating prescription costs daily and eliminating disputes from pharmacies about reimbursement, the ACI renders obsolete manually derived cost lists.
  • Adds Taketomo, We are pleased that the US Patent Trademark Office has recognized the uniqueness of our Ventegra ACI technology and granted this patent.

PolarityTE Receives Notice of Allowance for Chinese Patent

Retrieved on: 
Monday, July 12, 2021

PolarityTE, Inc. (Nasdaq: PTE) today announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No.

Key Points: 
  • PolarityTE, Inc. (Nasdaq: PTE) today announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No.
  • The Company continues to pursue additional patent applications in the United States and abroad related to its regenerative technologies, including SkinTE.
  • David Seaburg, Chief Executive Officer, commented, In less than two years, PolarityTE has grown its worldwide patent portfolio from zero allowed or granted patents to 12.
  • POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are registered trademarks of PolarityTE, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005140/en/

USPTO Issues Patent to Cinedapt to Adapt and Evolve the Film Industry From Extinction

Retrieved on: 
Wednesday, July 7, 2021

HOLLYWOOD, Calif., July 7, 2021 /PRNewswire/ -- Cinedapt, Inc. ( Cinedapt.com ) announced today that the United States Patent and Trademark Office has issued Michael Kureth the patent (U.S. Patent 11/051,064) to help prevent the film industry from extinction through its anti-piracy and Cinedaptive services.

Key Points: 
  • HOLLYWOOD, Calif., July 7, 2021 /PRNewswire/ -- Cinedapt, Inc. ( Cinedapt.com ) announced today that the United States Patent and Trademark Office has issued Michael Kureth the patent (U.S. Patent 11/051,064) to help prevent the film industry from extinction through its anti-piracy and Cinedaptive services.
  • Film piracy not only affects independent filmmakers.
  • The United States film economy has reported losses of $71 billion each year from piracy.As the film industry continues to offer same day theatrical and streaming releases, losses are projected to increase resulting in further job eliminations and diminished budgets resembling the decline of the music industry.
  • Cinedapt patents are issued to Michael Kureth.Cinedapt and Cinedaptive are registered trademarks of Michael Kureth.Cinedapt, Inc. is a Verified Vendor with the US Federal Contractor Registration, the world's largest third-party federal government registration firm.

CytoDyn Granted a Significant Patent by USPTO for Methods of Treating Coronavirus Infection with Leronlimab

Retrieved on: 
Tuesday, July 6, 2021

11,045,546 by the U.S. Patent and Trademark Office (USPTO) for methods of treating coronavirus infection (the Patent).

Key Points: 
  • 11,045,546 by the U.S. Patent and Trademark Office (USPTO) for methods of treating coronavirus infection (the Patent).
  • The Patent is owned by CytoDyn and its term of protection is expected to extend at least until June 15, 2040.
  • The USPTO prioritized examination of CytoDyns patent application, resulting in the grant of this Patent under the USPTOs COVID-19 Prioritized Examination Pilot Program in just about one (1) year.
  • The Patent discloses methods of treating hyperinflammationa common complication of COVID-19 caused by SARS-CoV-2 coronavirus infection.

GBT Filed a Patent for a Wireless Movement and Position Detection System

Retrieved on: 
Thursday, June 24, 2021

SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:GTCH ) ("GBT or the Company), filed a provisional patent (application number 63211573) with the U.S. Patent and Trademark Office (USPTO), for a real time movement and position detection method and system.

Key Points: 
  • SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:GTCH ) ("GBT or the Company), filed a provisional patent (application number 63211573) with the U.S. Patent and Trademark Office (USPTO), for a real time movement and position detection method and system.
  • An AI technology controls radio waves transmission and analyzes the reflected information to construct 2D and 3D images including real time movement.
  • The technology contemplates the inclusion of radio-based location system to enable accurate position of people and objects within the covered area.
  • GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology.